Article Details

Shanghai Henlius Biotech's HANSIZHUANG Secures EU Approval for Lung Cancer Treatment

Retrieved on: 2025-02-05 12:11:29

Tags for this article:

Click the tags to see associated articles and topics

Shanghai Henlius Biotech's HANSIZHUANG Secures EU Approval for Lung Cancer Treatment. View article details on hiswai:

Excerpt

Shanghai Henlius Biotech, Inc. announced that its anti-PD-1 monoclonal antibody, HANSIZHUANG, has received approval from the European Commission for ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo